Davis, CA, March 19th, 2013 – Gold Standard Diagnostics, Corp. (GSD, www.gsdx.us), a leading manufacturer and marketer of clinical laboratory instrumentation and assays for the in vitro diagnostics market, today announced it has established distribution partnerships for the ThunderBolt® Automated Immunoassay Analyzer in 18 countries throughout Europe, Latin America, Asia and the Middle East since the official global launch in early 2012. ThunderBolt® sales in the U.S. market also continue to grow as laboratories recognize the powerful and seamless automation solutions that Gold Standard Diagnostics offers.
Mature and emerging markets alike have responded to the comprehensive suite of fully automated features that the compact and cost-effective ThunderBolt® offers. As a result, the global sales and marketing network has grown substantially over the past year. Established markets, such as those in Europe, have widely accepted the ThunderBolt® with installations in Germany, Spain, Finland, Austria, Switzerland and Belgium. Additional countries with installed units include South Korea, Mexico, Vietnam, and Puerto Rico. Distribution partnerships and sales in China, Brazil, India and Canada are also imminent.
November 14th, 2012, Davis, CA – Simplify parasitology testing with Gold Standard Diagnostics’ (GSD) comprehensive line of assays for parasites and worms. GSD’s extensive portfolio of parasite tests provides laboratories with a reliable, single-source procurement option and access to a wide range of highly-consistent and cost-effective serological and stool assays.
Full line of Aspergillus fumigatus ELISA test options available from Gold Standard Diagnostics.
October 9th, 2012, Davis, CA – Gold Standard Diagnostics’ (GSD) comprehensive line of Aspergillus diagnostic tests enables clinical laboratories to prepare as the number of Aspergillus tests ordered is expected to rise significantly in the wake of 17,676 vials of potentially fungus-tainted steroids that have been recalled.
GSD’s complete solution for detection of Aspergillus IgG, IgM and IgA antibodies enables accurate detection of the fungus related to the current proliferation of fungal meningitis. The number of confirmed cases now exceeds 100 across 23 states, and many more cases are possible as symptoms may take up to a month to emerge. Laboratories should immediately procure sufficient Aspergillus tests to meet this expected increase in demand.
Davis, CA, September 5th, 2012 – Simplify and improve your clinical laboratory with single-step, direct ELISA measurement of Free Testosterone from Gold Standard Diagnostics (GSD). Compared to indirect, multi-step testing algorithms, GSD’s FDA Cleared Free Testosterone products save time and money while reducing the possibility of errors.
Reduce errors and cost with single-step Free Testosterone…
The ability to directly measure Free Testosterone eliminates the complication of taking multiple indirect measurements and calculating Free Testosterone through an algorithm. Diagnostic technologies have inherent limitations in terms of both precision and accuracy. Combining multiple procedures exacerbates these limitations and increases both the cost and opportunity for errors.
Generate multiple results and revenue from a single well.
Davis, CA, August 7th, 2012 – Simplify clinical diagnosis of autoimmune disease with Gold Standard Diagnostics’ (GSD) comprehensive offering of multiplex autoimmune assays. GSD has partnered with Theradiag (formerly known as Biomedical Diagnostics, BMD) to provide laboratories with the FIDIS™ suite of products for detection of the autoantibodies associated with connective tissue diseases, CREST syndrome, lupus erythematosus, rheumatoid arthritis, vasculitis, polymyositis, dermatomyositis, scleroderma, Sjögren syndrome, thyroid syndromes, Celiac and many others. Major benefits of the FIDIS™ multiplex product suite include: up to 13 results in a single well, reduced labor and overhead, increased throughput, small sample volume and full automation.
Simplify Your Laboratory Experience with Multiplex…
The 2012 AACC Lab Expo was the biggest year yet for Gold Standard Diagnostics. The huge response to the ThunderBolt® EIA+CLIA Platform, our Extensive Product Menu and Outstanding Customer Service was extremely exciting. We look forward to working with each of you to Simplify Your Laboratory Experience!
We will be sorting through all of the new contacts we made and following up over the next few weeks. In the meantime, please don't hesitate to contact us with any questions you may have about our instrumentation, reagents, service or company in general.